Journal article
Changes in estrogen receptor (ER), progesterone receptor (PR) and HER2/neu status with time: Discordance rates between primary and metastatic breast pathology samples
Abstract
1024
Background: The occurrence of changes in tumor receptor profile (ER, PR and HER-2/neu) between primary and metastatic tissue has been recognised and may have significant treatment implications. Previous reports on receptor discordance rates have tended to be from sub-studies of clinical trials. We sought to evaluate the degree of ER, PR and HER-2/neu receptor discordance in patients treated at two Canadian cancer centres. …
Authors
Broom RJ; Tang P; Simmons C; Bordeleau L; O’Malley FP; Miller N; Andrulis IL; Brenner DM; Clemons M
Journal
Journal of Clinical Oncology, Vol. 25, No. 18_suppl, pp. 1024–1024
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 20, 2007
DOI
10.1200/jco.2007.25.18_suppl.1024
ISSN
0732-183X